Amgen Wins Appeal in US Patent Case Over Generic Psoriasis Drugs Amgen Wins Appeal in US Patent Case Over Generic Psoriasis Drugs

Amgen convinced a US appeals court on Wednesday to uphold patents that barred generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals and Novartis ' Sandoz.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news